Skip to content
healthcare.dev
Get a free key

Sitagliptin and Metformin Hydrochloride

NDC 70710-2037, sitagliptin and metformin hydrochloride, tablet, film coated, extended release, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-2037
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA216778
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2037 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SITAGLIPTIN50 mg/1
  • METFORMIN HYDROCHLORIDE1000 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
70710-2037-67071020370660 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70710-2037-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d3a728a0-decb-4340-8ee4-c5e27c13eb19

Use it

Look up 70710-2037 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2037 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-2037. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.